Are peptides legal to buy in Australia?

It depends on the specific peptide and its regulatory status. Approved peptide medicines listed on the Australian Register of Therapeutic Goods (ARTG) can be legally obtained with a valid prescription where required. Unapproved peptide products — including many sold online as 'research chemicals' — are not legally authorised for supply in Australia as therapeutic goods. The TGA has taken compliance action in this space.

Do peptides need to be injected?

Many pharmaceutical peptides are administered by subcutaneous injection because oral bioavailability is poor — digestive enzymes break down peptide bonds before the molecule can be absorbed intact. Some smaller peptides and certain formulations can be delivered via other routes (intranasal, for example), and research into oral delivery systems is ongoing. Route of administration depends on the specific molecule and its pharmacokinetic profile.

What is the difference between a peptide and a protein?

Both are chains of amino acids linked by peptide bonds. The conventional distinction is length: chains of roughly fewer than 50 amino acids are called peptides; longer chains are called proteins. There is no universally fixed cut-off, and some small proteins (like insulin, at 51 amino acids) sit right at the boundary. Proteins also typically fold into complex three-dimensional structures, though some peptides have secondary structure as well.

Can a GP prescribe a peptide that isn't on the ARTG?

In specific circumstances, a medical practitioner can apply to access an unapproved therapeutic good for an individual patient through the TGA's Special Access Scheme (SAS), or seek Authorised Prescriber status for a particular unapproved good. These are formal TGA pathways with their own criteria and oversight requirements. They are not a general mechanism for obtaining grey-market products.

Are collagen supplements the same as the peptides sold for bodybuilding or anti-ageing?

No. Collagen hydrolysates sold as food supplements are regulated differently from pharmaceutical or injectable peptides. They're typically classified as foods or complementary medicines depending on the claims made, and are taken orally. Pharmaceutical-style peptide injectables designed to mimic growth factors or hormonal signals are a distinct category, with different regulatory requirements and a different evidence base.

Peptides: Frequently Asked Questions

By Tom Whitfield · 30 May 2026 · 8 min read

A bunch of different colored balloons in a vase

Roughly three questions land in my inbox every week about peptides, and about half of them start with the same assumption: that "natural" or "research" framing puts a substance outside the usual regulatory orbit. It doesn't. So before I get into the Q&A proper, let's be clear about where these molecules sit under Australian law , and then work through the chemistry, the classification, and the questions people actually ask.

I've been building the reference library for this site for a while now, and the peptide section has grown faster than almost any other. That's partly because the science is genuinely interesting, and partly because the grey-market supply picture in Australia has made it a live regulatory story. The TGA has been active. Worth paying attention to.

The basics: what a peptide actually is

What is a peptide?

A peptide is a short chain of amino acids linked together by peptide bonds , the covalent bond formed when the carboxyl group of one amino acid joins the amino group of the next, releasing water in the process. The convention is that chains of fewer than roughly 50 amino acids are called peptides; longer chains become proteins. That boundary is somewhat arbitrary and you'll see it argued about in biochemistry textbooks, but it's the working definition used in most regulatory and pharmacological contexts.

Where do peptides come from?

They're found throughout nature: in the human body (hormones, neuropeptides, antimicrobial molecules), in plants, in animal venoms, in fungi. They're also synthesised in laboratories. Some pharmaceutical peptides are derived from biological sources; others are entirely synthetic sequences designed to mimic or modify a natural molecule's activity. The origin , natural vs synthetic; does not determine regulatory status in Australia.

How are peptides different from proteins?

Mostly size and, often, structural complexity. A protein like insulin has a defined three-dimensional folded structure held together by disulfide bonds and other forces. Shorter peptides may be linear and relatively flexible. That said, insulin itself is a small protein of 51 amino acids, again, the line is blurry. What matters pharmacologically is how a particular molecule interacts with its target receptor and how the body handles it.

Peptides in the body: mechanisms and signalling

How do peptides signal in the body?

Many endogenous (naturally occurring) peptides act as ligands, they bind to receptors on cell surfaces or inside cells and trigger a downstream response. Insulin binds insulin receptors to facilitate glucose uptake. Glucagon-like peptide-1 (GLP-1) binds GLP-1 receptors in the pancreas and elsewhere, influencing insulin secretion and gastric emptying. Endorphins bind opioid receptors. The specificity of the binding; which receptor, where, at what affinity, determines what happens.

What does "half-life" mean for a peptide?

Half-life is the time it takes for the concentration of a substance in the body to reduce by half. Most natural peptides have short half-lives because enzymes called proteases break the peptide bonds rapidly. A molecule like native GLP-1 has a plasma half-life of only a couple of minutes. One of the core challenges in pharmaceutical peptide development is extending half-life through structural modification, adding fatty acid chains, altering the amino acid sequence, or attaching carrier molecules. Understanding how a substance moves through the body is part of the broader study of pharmacokinetics.

Are peptides absorbed orally?

Generally poorly. The digestive system breaks down most peptide bonds before the molecule can be absorbed intact, and larger peptides don't cross the intestinal wall efficiently. This is why many pharmaceutical peptides are administered by injection; often subcutaneous injection (into the tissue just below the skin). Some smaller peptides do survive oral delivery in meaningful amounts, and there is active research into oral formulations using protective coatings or modified sequences, but most peptide drugs currently on the market are injectables or intranasal preparations.

Regulation in Australia: the part that matters most

How does the TGA classify peptides?

There's no single "peptide schedule." A peptide's classification depends on what it is, what it does, and whether it's been assessed and approved. Approved peptide medicines, those listed on the Australian Register of Therapeutic Goods (ARTG) after TGA evaluation, are regulated like any other medicine. Depending on the substance, they may be Schedule 4 (prescription only) or Schedule 8 (controlled drug) under the Poisons Standard. Some are available over the counter. The schedule is assigned on a substance-by-substance basis.

What about peptides sold as "research chemicals" or "not for human use"?

This is the question I get most often, and the answer is straightforward: labelling a substance "for research purposes only" or "not for human use" does not change its regulatory status under Australian law if it is, in substance, a therapeutic good. The TGA has explicitly addressed this. If a product contains an ingredient that has a physiological effect in humans and is being supplied with the implicit or explicit expectation of human use, it is likely to be captured as a therapeutic good regardless of how it's labelled. Supplying unapproved therapeutic goods in Australia is illegal under the Therapeutic Goods Act 1989.

Have there been enforcement actions?

Yes. The TGA has published public statements and compliance actions targeting the supply of unapproved peptide products; particularly injectable peptides marketed for body composition and anti-ageing purposes. These products are frequently unapproved, and supplying them without the appropriate ARTG listing or applicable exemption is illegal in Australia. This is not a grey area the TGA is leaving alone.

Can a doctor prescribe an unapproved peptide?

In specific circumstances, yes. The Special Access Scheme (SAS) allows medical practitioners to access unapproved therapeutic goods for individual patients where clinical need exists and the appropriate category of access applies. The Authorised Prescriber pathway allows a specialist to apply to the TGA for approval to prescribe a specific unapproved good to a class of patients. Both pathways involve TGA oversight; neither is a general licence to obtain and supply unapproved peptides freely.

Does Good Manufacturing Practice (GMP) apply?

For any peptide that falls within the definition of a therapeutic good and is being manufactured for supply in Australia, GMP requirements apply. GMP standards govern the conditions, processes and quality controls under which a medicine is produced. Products supplied outside these frameworks, including many grey-market injectables, have not been assessed for quality, purity, or correct dosage, which carries its own set of risks independent of the scheduling question.

Specific peptide types: common questions

What is a GLP-1 receptor agonist?

A GLP-1 receptor agonist is a molecule; peptide or otherwise, that binds to and activates GLP-1 receptors. GLP-1 (glucagon-like peptide-1) is a naturally occurring incretin hormone. Pharmaceutical GLP-1 receptor agonists are approved medicines prescribed for specific indications; they are not supplements, and they require a valid prescription. There is a substantial grey market in unapproved versions of these molecules in Australia. The TGA has made its position on that supply chain clear.

What are "peptide stacks" and are they legal?

The term "stack", borrowed from bodybuilding culture; refers to using multiple substances simultaneously. Whether any given combination is legal depends entirely on the scheduling status of each individual substance. No combination or framing makes an unapproved therapeutic good legal to supply. I'll be honest: some of the marketing language around stacks is designed to obscure this, and I find that irritating.

Are collagen peptides the same as pharmaceutical peptides?

No, though they're all peptides in the chemical sense. Collagen hydrolysates and collagen peptides sold as food supplements occupy a different regulatory category from pharmaceutical peptide injectables. They're typically regulated as foods or complementary medicines depending on the claims made. The regulatory pathway and oversight are different. What the body does with an orally ingested collagen peptide is also a different story from what happens with a subcutaneous injection of a synthetic peptide designed to mimic a growth-factor signal.

A note on the research landscape

Is there good clinical evidence for peptides used outside approved indications?

This is where I have to put on my librarian hat properly. The short version is: it varies enormously. For approved pharmaceutical peptides, certain GLP-1 agonists, for example, there is extensive Phase III trial data. For many of the peptides circulating in grey-market fitness and anti-ageing contexts, the human clinical evidence is sparse, preliminary, or nonexistent. A number of these molecules have been studied only in animal models or in small, non-randomised human studies. Extrapolating from rodent pharmacology to human outcomes is a move that requires a lot of caveats. I've spent enough time in PubMed to know that "a study found" and "there is clinical evidence" are not the same thing.

(Between birdwatching sessions last month I went back through a handful of frequently cited peptide studies and was struck by how many had no comparator group and sample sizes in the low double digits. Worth keeping that in mind when reading secondary sources on this topic.)

Where can I find reliable regulatory information?

The TGA's website (tga.gov.au) is the primary source for Australian regulatory status. The ARTG public search allows you to check whether a specific product is approved. For scheduling, the Poisons Standard is publicly available. For mechanism and pharmacology, PubMed (ncbi.nlm.nih.gov) indexes the peer-reviewed literature. Neither a forum post nor a supplier's product page is a substitute for these.

Sources

, Tom Whitfield, Health librarian, references & fact-checking

]]>

Common questions

Are peptides legal to buy in Australia?: It depends on the specific peptide and its regulatory status. Approved peptide medicines listed on the Australian Register of Therapeutic Goods (ARTG) can be legally obtained with a valid prescription where required. Unapproved peptide products — including many sold online as 'research chemicals' — are not legally authorised for supply in Australia as therapeutic goods. The TGA has taken compliance action in this space.
Do peptides need to be injected?: Many pharmaceutical peptides are administered by subcutaneous injection because oral bioavailability is poor — digestive enzymes break down peptide bonds before the molecule can be absorbed intact. Some smaller peptides and certain formulations can be delivered via other routes (intranasal, for example), and research into oral delivery systems is ongoing. Route of administration depends on the specific molecule and its pharmacokinetic profile.
What is the difference between a peptide and a protein?: Both are chains of amino acids linked by peptide bonds. The conventional distinction is length: chains of roughly fewer than 50 amino acids are called peptides; longer chains are called proteins. There is no universally fixed cut-off, and some small proteins (like insulin, at 51 amino acids) sit right at the boundary. Proteins also typically fold into complex three-dimensional structures, though some peptides have secondary structure as well.
Can a GP prescribe a peptide that isn't on the ARTG?: In specific circumstances, a medical practitioner can apply to access an unapproved therapeutic good for an individual patient through the TGA's Special Access Scheme (SAS), or seek Authorised Prescriber status for a particular unapproved good. These are formal TGA pathways with their own criteria and oversight requirements. They are not a general mechanism for obtaining grey-market products.
Are collagen supplements the same as the peptides sold for bodybuilding or anti-ageing?: No. Collagen hydrolysates sold as food supplements are regulated differently from pharmaceutical or injectable peptides. They're typically classified as foods or complementary medicines depending on the claims made, and are taken orally. Pharmaceutical-style peptide injectables designed to mimic growth factors or hormonal signals are a distinct category, with different regulatory requirements and a different evidence base.